XETRA - Delayed Quote EUR

SCHOTT Pharma AG & Co. KGaA (1SXP.DE)

24.38

-0.64

(-2.56%)

At close: 5:35:25 PM GMT+1

SCHOTT Pharma KGaA Full Year 2024 Earnings: EPS Beats Expectations

SCHOTT Pharma KGaA ( ETR:1SXP ) Full Year 2024 Results Key Financial Results Revenue: €957.1m (up 6.5% from FY 2023...

Simply Wall St. 28 days ago

SHTPY
A Look At The Fair Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

Key Insights The projected fair value for SCHOTT Pharma KGaA is €30.45 based on 2 Stage Free Cash Flow to Equity With...

Simply Wall St. last month

SHTPY
SCHOTT Pharma AG & Co. KGaA's (ETR:1SXP) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

With its stock down 11% over the past three months, it is easy to disregard SCHOTT Pharma KGaA (ETR:1SXP). However...

Simply Wall St. 2 months ago

SHTPY
Schott Pharma AG & CO KGaA (WBO:1SXP) Q3 2024 Earnings Call Highlights: Strong Revenue ...

Schott Pharma AG & CO KGaA (WBO:1SXP) reports a 21% revenue increase and raises its full-year growth guidance, while addressing challenges in production and currency impacts.

GuruFocus.com 3 months ago

SHTPY
Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry "Alliance for RTU"

PIOMBINO DESE, Italy, September 26, 2024--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, together with Gerresheimer AG (MDAX: GXI) and SCHOTT Pharma AG & Co. KGaA (MDAX: 1SXP), announced today that they have entered into a strategic industry alliance ("Alliance for RTU") to support market adoption of Ready-to-Use (RTU) vials and cartridges.

Business Wire 3 months ago

GRRMF

GRRMY

SHTPY
SCHOTT Pharma AG & Co. KGaA Just Beat EPS By 52%: Here's What Analysts Think Will Happen Next

As you might know, SCHOTT Pharma AG & Co. KGaA ( ETR:1SXP ) just kicked off its latest quarterly results with some very...

Simply Wall St. 4 months ago

SHTPY
SCHOTT Pharma KGaA Third Quarter 2024 Earnings: Beats Expectations

SCHOTT Pharma KGaA ( ETR:1SXP ) Third Quarter 2024 Results Key Financial Results Revenue: €253.6m (up 15% from 3Q...

Simply Wall St. 4 months ago

SHTPY
Is Weakness In SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

With its stock down 5.5% over the past month, it is easy to disregard SCHOTT Pharma KGaA (ETR:1SXP). But if you pay...

Simply Wall St. 8 months ago

1SXP.DE
-2.56%
Estimating The Fair Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

Key Insights SCHOTT Pharma KGaA's estimated fair value is €34.80 based on 2 Stage Free Cash Flow to Equity SCHOTT...

Simply Wall St. 9 months ago

STTPF

Performance Overview

Return	1SXP.DE	DAX P
YTD	-2.32%	+1.82%
1-Year	-27.16%	+21.35%
3-Year	-18.73%	+26.45%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

SCHOTT Pharma AG & Co. KGaA (1SXP.DE)

SCHOTT Pharma KGaA Full Year 2024 Earnings: EPS Beats Expectations

A Look At The Fair Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

SCHOTT Pharma AG & Co. KGaA's (ETR:1SXP) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Schott Pharma AG & CO KGaA (WBO:1SXP) Q3 2024 Earnings Call Highlights: Strong Revenue ...

Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry "Alliance for RTU"

SCHOTT Pharma AG & Co. KGaA Just Beat EPS By 52%: Here's What Analysts Think Will Happen Next

SCHOTT Pharma KGaA Third Quarter 2024 Earnings: Beats Expectations

Is Weakness In SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Estimating The Fair Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

Performance Overview